Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B.
Bassetti
Matteo
M
Bisio
Francesca
F
Di Biagio
Antonio
A
Pierri
Ivana
I
Balocco
Manuela
M
Soro
Ornella
O
Cruciani
Mario
M
Bassetti
Dante
D
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D000077336:Caspofungin; D004359:Drug Therapy, Combination; D054714:Echinocandins; D017809:Fatal Outcome; D005334:Fever / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host; D007951:Leukemia, Myeloid / Q000150:complications / Q000188:drug therapy; D055666:Lipopeptides; D008081:Liposomes; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D010455:Peptides / Q000627:therapeutic use*; D010456:Peptides, Cyclic; D014250:Trichosporon
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D008081:Liposomes; D010455:Peptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin